Free Trial

Kalaris Therapeutics (KLRS) SEC Filings & 10K Form

Kalaris Therapeutics logo
$3.56 +0.48 (+15.58%)
As of 08/28/2025 04:00 PM Eastern

Recent Kalaris Therapeutics SEC Filings

DateFilerForm TypeView
08/13/2025
7:11 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
7:16 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
6:40 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form ARS
07/01/2025
6:30 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEF 14A
07/01/2025
6:35 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEFA14A
06/20/2025
6:20 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
1:06 PM
EcoR1 Capital, LLC (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
7:09 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
3:18 PM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
4:04 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:08 PM
Jovan-Embiricos Morana (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:20 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:27 PM
Hagen Brett R (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:03 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:41 PM
Hallal David (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
7:21 AM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATTERSON LEONE D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
7:12 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
6:19 PM
Hagen Brett R (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3/A
03/25/2025
6:38 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
6:40 PM
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D
03/20/2025
3:32 PM
GILEAD SCIENCES, INC. (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form SCHEDULE 13G/A
03/18/2025
4:44 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:45 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:37 PM
ADAMIS ANTHONY P (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:40 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:41 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:43 PM
Feinsod Matthew (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:25 PM
Dybbs Michael (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:27 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:30 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:14 PM
ADAMIS ANTHONY P (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:17 PM
Feinsod Matthew (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:20 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:21 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:04 PM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:18 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:30 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
10:51 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:55 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:56 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Altucher: It Looks Like My Trump prediction is coming true (Ad)

New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.tc pixel

See Altucher’s Trump crypto prediction here
02/14/2025
12:17 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
11:15 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form EFFECT
02/10/2025
3:19 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 424B3
01/24/2025
1:51 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
1:55 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
2:03 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:39 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:41 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
6:44 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
01/10/2025
6:42 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:21 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:23 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
12/11/2024
4:07 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
12/06/2024
6:23 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEF 14A
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:06 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:09 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:10 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
7:26 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)

In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel

Watch Alex's "Next Magnificent Seven" presentation now.
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KLRS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners